03/10/2026
A milestone for Parkinson’s care in New England. Dr. Rees Cosgrove and Dr. John Rolston recently completed the region’s first case using the newly approved PTT target therapy, expanding treatment options for patients by addressing a broader range of Parkinson’s symptoms. This innovative approach reflects our continued commitment to advancing neurosurgical care and bringing the latest therapies to patients.